The Ultimate Dermatology Billing Guide

Free Demo

📌  WHAT'S INSIDE THIS GUIDE

Dermatology practices lose an estimated 15–25% of collectible revenue to billing errors, undercoding, and unworked claim denials every year. This guide is your antidote. Whether you're a dermatologist running an independent practice, an office manager trying to reduce AR days, or a billing team looking to sharpen your coding skills this is the most complete, 2026-ready dermatology billing resource available.

Inside this guide you'll find:

▸  2026-updated CPT codes for every major dermatology procedure category

▸  ICD-10 reference for the most common skin conditions and malignancies

▸  Modifier guide with real-world dermatology examples and common pitfalls

▸  Complete Mohs surgery and skin biopsy billing breakdowns

▸  Documentation checklists that survive payer audits and OIG scrutiny

▸  Top 10 claim denial reasons and exactly how to beat every one

▸  Revenue cycle KPIs, best practices, and audit-proofing strategies

▸  An honest in-house vs. outsourced billing comparison with scoring matrix

▸  10-question FAQ covering the most-Googled dermatology billing questions

⚠️  IMPORTANT DISCLAIMER

This guide is for educational and informational purposes only and does not constitute professional billing, coding, legal, or financial advice. CPT codes are © American Medical Association. All fee amounts are approximate Medicare national averages. Always verify codes, fees, and payer policies with current CMS documentation and your contracted payer agreements. See full disclaimer at the end of this document.

📋  Table of Contents

#	Section
01	Introduction: Why Dermatology Billing Is Uniquely Challenging in 2026
02	The Dermatology Revenue Cycle — An 8-Step Overview
03	Dermatology CPT Codes 2026 — Complete Reference by Category
04	ICD-10 Codes for Common Dermatology Conditions
05	Modifiers in Dermatology Billing — How to Use Them Right
06	Mohs Surgery Billing — The Complete Breakdown
07	Skin Biopsy Billing — Technique Is Everything
08	Documentation Requirements — What Survives an Audit
09	Top 10 Claim Denial Reasons + Fix Strategies
10	Revenue Cycle Best Practices for Dermatology (2026)
11	Compliance & Audit Risk in Dermatology Billing
12	In-House vs. Outsourced Dermatology Billing — An Honest Comparison
13	Billing Partner Scoring Matrix
14	FAQ — 10 Most-Asked Dermatology Billing Questions
15	Full Disclaimer

01.  Introduction: Why Dermatology Billing Is Uniquely Challenging in 2026

Dermatology is one of the highest-volume, procedure-intensive specialties in outpatient medicine — and one of the most billing-intensive. A single patient visit can generate multiple CPT codes, require stacked modifiers, and hinge on documentation details that most practices overlook until a denial arrives.

In 2026, the billing landscape has grown sharper. Payers are deploying AI-driven claim review tools that flag underdocumented records faster than any human auditor. CMS continues to tighten the definition of medical necessity for skin procedures. And NCCI bundling edits — the rules that govern which codes can be billed together — are updated quarterly, making it harder for billing teams to keep current.

The financial stakes are real: dermatology practices consistently lose between 15% and 25% of collectible revenue to billing errors, incorrect coding, and unworked denials. For a practice collecting $1.2 million per year, that's up to $300,000 walking out the door — quietly, systematically, and preventably.

This guide doesn't just list codes. It explains how dermatology billing actually works in the real world — the decisions made at the front desk, in the exam room, and in the billing office that either protect or erode your revenue. Let's dig in.

15–25% Revenue Lost to Billing Errors Annually

<5% Denial Rate Target — Top Dermatology Practices

>95% Clean Claim Rate (First Pass) Benchmark

<30 Target Days in AR for Dermatology Billing

02.  The Dermatology Revenue Cycle An 8-Step Overview

Medical billing is a lifecycle, not a single event. In dermatology, that lifecycle runs at high speed with same-day procedures, multi-code encounters, and payer rules that don't forgive documentation gaps. Here's how the complete revenue cycle looks inside a high-performing dermatology practice:

⚡  Revenue Cycle Quick Win

Practices that verify insurance eligibility 48 hours before each appointment rather than at check-in — reduce front-end denials by an average of 28%. Build this into your scheduling workflow. It's the single highest-ROI process change available to most dermatology practices.

03.  Dermatology CPT Codes 2026 Complete Reference by Category

CPT codes are the language you use to communicate with payers about what was done. In dermatology, selecting the correct code isn't just a billing task it's a clinical documentation task. The code you bill must reflect exactly what was performed and what was documented. No more, no less.

3A.  Evaluation & Management (E&M) Codes

Since the 2021 AMA E&M overhaul fully refined and maintained through 2026 dermatology E&M coding is based on either Medical Decision Making (MDM) or total physician time. Both pathways are valid; your documentation determines which applies.

💡  E&M Coding Tip for 2026

You no longer need to count history bullets or exam elements. The dominant pathway in dermatology is Medical Decision Making (MDM) which evaluates the number and complexity of problems addressed, data reviewed, and the risk of management decisions. Document what you assessed and what you decided. Let the MDM level flow from that.

3B.  Skin Biopsy CPT Codes

CMS overhauled biopsy coding in 2019 with codes 11102–11107 replacing the old 11100/11101 structure. These codes remain fully in effect through 2026. The critical rule: code selection is based on biopsy technique — not lesion type, diagnosis, or depth of concern.

CPT Code	Description	Technique Used	Code Type
11102	Tangential biopsy, 1st lesion	Shave, scoop, saucerize — shallow, parallel to skin surface	Primary
11103	Each additional tangential biopsy (add-on)	Same technique, additional lesion same session	Add-On ×
11104	Punch biopsy, 1st lesion	Circular punch — full depth through dermis or subcutis	Primary
11105	Each additional punch biopsy (add-on)	Same technique, additional lesion same session	Add-On ×
11106	Incisional biopsy, 1st lesion	Sharp incision, wedge or ellipse — maximum tissue depth	Primary
11107	Each additional incisional biopsy (add-on)	Same technique, additional lesion same session	Add-On ×

3C.  Lesion Excision — Benign and Malignant

Excision codes are tiered by lesion type (benign vs. malignant), anatomical location, and the excised specimen size including the narrowest surgical margin. The margin measurement not just the lesion determines the code.

3D.  Destruction Codes — Premalignant and Malignant Lesions

CPT Code	Description	Key Notes
17000	Destruction, premalignant lesion, 1st lesion	Any method (cryo, laser, chemical); document technique and diagnosis supporting medical necessity
17003	Each additional lesion, 2nd–14th (add-on)	Requires 17000 as primary; billed once per additional lesion; document exact count
17004	Destruction, 15 or more premalignant lesions	Replaces 17000+17003 combo when 15+ lesions treated; high audit scrutiny — document count
17110	Destruction, warts or molluscum, 1–14 lesions	Flat warts, plantar warts, molluscum contagiosum; distinct from AK codes
17111	Destruction, 15 or more warts or molluscum	Same session only; document lesion count clearly in chart note
17260–17286	Destruction, malignant lesions by size and site	Higher RVU than premalignant; requires prior pathologic confirmation of malignancy

04.  ICD-10 Codes for Common Dermatology Conditions (2026)

Payers increasingly use ICD-10 specificity as a medical necessity trigger. Vague or unspecified codes are a top driver of claim denials and a red flag in post-payment audits. The table below covers the most frequently billed dermatology diagnoses — with notes on how specificity affects reimbursement and audit risk.

ICD-10 Code	Condition	Coding Specificity Note
L57.0	Actinic keratosis	Directly supports destruction codes 17000–17004; link diagnosis to CPT carefully
L70.0	Acne vulgaris	Specify type when possible — cystic (L70.0), comedonal; impacts treatment code selection
L20.9	Atopic dermatitis, unspecified	Use L20.0–L20.89 for eyelid, flexural, or other specific subtypes when documented
L40.0	Psoriasis vulgaris	Distinguish from guttate (L40.4) or pustular (L40.1) — each has different clinical implications
L50.9	Urticaria, unspecified	L50.0 = allergic urticaria; more specific when trigger is identified and documented
C44.91	Malignant neoplasm of skin, unspecified	Always specify site and cell type (BCC vs. SCC vs. other); critical for Mohs justification
C43.xx	Malignant melanoma of skin	Site-specific + laterality required; triggers High MDM for E&M level; never leave unspecified
D22.9	Melanocytic nevi, unspecified	Specify site to align with excision code location; supports medical necessity for removal
B07.9	Viral wart, unspecified	Use B07.0 (plantar), B07.8 (other) for specificity; B07.9 is audit-prone
L82.1	Seborrheic keratosis	L82.0 = inflamed seborrheic keratosis; distinction affects medical necessity for removal
L63.9	Alopecia areata, unspecified	Specify extent: L63.0 (totalis), L63.1 (universalis) when documented clinically
L72.0	Epidermal cyst	Always document anatomical site; links to incision/drainage or excision procedure codes
L60.0	Ingrowing nail	Specify laterality; common in general dermatology; supports nail procedure coding

🚨  Coding Trap: Unspecified Codes Are a Denial Magnet

Any ICD-10 code ending in ".9" (unspecified) should be a last resort, not a default. Payers flag high rates of unspecified codes as a documentation weakness indicator — and it triggers claim reviews. For skin malignancies especially, always code to the specific site, cell type, and laterality whenever your documentation supports it. The more specific the code, the stronger your medical necessity argument.

05.  Modifiers in Dermatology Billing How to Use Them Right

Modifiers are two-digit codes that tell payers something unusual or additional happened with a service. In dermatology, modifier errors are the single most common cause of preventable claim denials. Here's the complete 2026 modifier reference with real-world context for each one.

⚠️  Modifier -25: The Most Misunderstood Code in Dermatology

Modifier -25 is required every time you bill an E&M visit on the same day as a procedure. But here's where practices go wrong: the E&M must be clearly documented as addressing a clinical issue that goes meaningfully beyond the routine pre-procedure assessment. "Patient here for biopsy, site prepped" is not a -25 E&M. "Patient presents with three new pigmented lesions across the back and chest; discussed surveillance strategy for dysplastic nevi; decided to biopsy the most atypical lesion today based on asymmetry and color variation" that is a -25 E&M.

06.  Mohs Surgery Billing — The Complete Breakdown

Mohs micrographic surgery is the most technically demanding procedure in dermatology billing — and carries the highest audit risk. Getting it right requires understanding not just the CPT codes, but the documentation structure, tissue block counting, and payer-specific prior authorization requirements.

In Mohs surgery, the operating surgeon also functions as the pathologist — examining 100% of the surgical margins in real time before deciding whether to remove an additional stage. This dual surgeon-pathologist role is why Mohs codes carry high RVUs and require strict, stage-by-stage documentation.

CPT Code	Description	Location Criteria	Key Documentation Requirement
17311	Mohs, Stage 1 — 1st tissue block	Head, neck, hands, feet, genitalia	Highest RVU; document anatomical site explicitly — location determines the code
17312	Each additional stage — add-on	Same high-risk sites as 17311	Requires same-day documentation of positive margins from prior stage
17313	Mohs, Stage 1 — 1st tissue block	Trunk, extremities (excl. hands/feet)	Lower RVU than head/neck; still requires complete stage documentation
17314	Each additional stage — add-on	Trunk/extremities (same as 17313)	Stage number and margin status must appear in operative note
17315	Each additional tissue block per stage — add-on	All Mohs sites	Applied per additional block within each stage; document exact block count per stage

Critical Mohs Billing Rules for 2026

▸  Always specify anatomical location — head/neck/hands/feet (17311) commands a higher RVU than trunk/extremities (17313)

▸  Document the number of stages AND the number of tissue blocks per stage separately in the operative note

▸  Each 17315 code requires documentation of how many tissue blocks were processed in that specific stage

▸  Confirm fresh-tissue, real-time pathology interpretation — most payers require this to be recorded in the op note, not attached separately

▸  Verify prior authorization status before scheduling — most commercial payers require PA for Mohs surgery

🔍  2026 OIG Audit Focus: Mohs Surgery on Low-Risk BCCs

The OIG has identified Mohs surgery performed for low-risk basal cell carcinomas on the trunk as an active audit target in 2026. If your practice performs Mohs on trunk BCCs, pre-operative documentation must clearly establish why Mohs — rather than standard excision — was medically necessary. Clinical factors such as recurrent tumor, scar tissue, poor wound healing history, or specific patient risk factors should be documented explicitly and completely before the procedure begins.

07.  Skin Biopsy Billing — Technique Is Everything

Skin biopsy billing is where the most coding errors occur in dermatology — and where those errors are most recoverable with proper staff training and EHR template design. The 2019 code overhaul changed the rules completely, and in 2026, many practices still have billing habits rooted in the old 11100/11101 world.

The rule that governs everything: the CPT code you select must reflect the technique used — not the diagnosis, not the size, and not the depth of clinical concern. The technique determines the code.

Technique	1st Lesion Code	Add-On Code	When to Select This Technique Code
Tangential (shave/scoop)	11102	11103	Superficial lesions; instrument removes tissue parallel to skin surface without full-depth penetration
Punch biopsy	11104	11105	Circular punch instrument to dermis or subcutaneous tissue; provides full-thickness core sample
Incisional	11106	11107	Sharp instrument creates incision — wedge or ellipse — for deep or subcutaneous tissue; maximum depth
Shave removal (not biopsy)	11300–11313	N/A	Intent is complete removal of a benign lesion, not tissue sampling; this is a different code family entirely

Multiple Biopsy Billing Rules

▸  Same technique, multiple lesions: Report the primary code (11102/04/06) once, then the add-on code for each additional lesion

▸  Different techniques on same day: Report the primary code for the first lesion of each technique separately (e.g., 11102 + 11104 if both tangential and punch are performed)

▸  Modifier -59 may be required when billing two different primary biopsy codes on the same claim

▸  If a physician saucerizes a lesion and removes it entirely, this may be a shave removal (11300 series) rather than a biopsy — intent and documentation drive the code decision

08.  Documentation Requirements What Survives an Audit

Documentation is not a formality — it is the financial proof that justifies every claim you submit. In a post-payment audit, your medical record is the only thing standing between your practice and a repayment demand. Here's what must be present, by encounter type.

E&M Visit Documentation Checklist

✓  Chief complaint documented in the patient's own words or clinically equivalent language

✓  History of present illness with relevant onset, duration, character, and associated symptoms

✓  Physical exam findings — for dermatology: number, type, size, and location of lesions

✓  Medical Decision Making clearly supported: problems addressed, data reviewed, risk of management

✓  Assessment and plan — what was decided, prescribed, ordered, referred, or deferred

✓  If billing by time: total encounter time AND brief breakdown of time components documented

Procedure Documentation Checklist

✓  Clinical indication for the procedure — the diagnosis must link directly to the CPT code

✓  Technique explicitly specified — especially for biopsies (tangential vs. punch vs. incisional)

✓  Anatomical location with specificity and laterality where applicable

✓  Lesion/specimen size — for excisions, include surgical specimen size with narrowest margin

✓  Anesthesia method documented (local, topical, regional)

✓  Post-procedure care plan, dressing applied, and patient instructions documented

✓  Informed consent documented — either within the note or with reference to a signed consent form

Mohs Surgery Documentation Checklist

✓  Pre-operative diagnosis and rationale for Mohs technique documented

✓  Anatomical map or diagram for each surgical stage included in operative note

✓  Number of stages and number of tissue blocks per stage clearly documented

✓  Fresh-tissue, real-time pathology interpretation recorded — same-day, by the operating surgeon

✓  Final defect size documented prior to reconstruction planning

✓  Reconstruction note (if applicable) with defect dimensions separate from Mohs map

Same-Day E&M + Procedure (Modifier -25) Documentation

✓  E&M note addresses a clinical problem distinct from — or significantly beyond — the pre-procedure assessment

✓  MDM or time documentation supports the selected E&M level independently of the procedure

✓  A different, broader, or more complex clinical issue is clearly addressed within the E&M body of the note

📁  Documentation Reality Check

In dermatology post-payment audits, the most common finding is not intentional fraud — it's insufficient documentation to support the level of service billed. E&M downcoding from 99214 to 99212, biopsy technique codes unsupported by operative notes, and -25 modifier claims where the E&M cannot stand alone independently are the three highest-frequency findings. Investing in proper documentation templates and quarterly provider education delivers far greater ROI than any billing technology.

09.  Top 10 Claim Denial Reasons + Fix Strategies

Denials don't mean your claim is dead they mean you have work to do. The critical insight most practices miss is this: most dermatology denials are preventable on the front end, and most are recoverable if you work them fast and correctly. Here are the top 10 denial reasons in dermatology billing and exactly what to do about each one.

📊  Know Your Denial Benchmarks

Where top-performing dermatology practices stand: Clean claim rate >95% | First-pass denial rate <5% | Denial overturn rate >70% | Days in AR <30 | Net collection rate >96%. If your numbers fall outside these ranges, the top denial reasons above contain the most likely culprits. Start with your highest-dollar denial reasons — that is where the biggest immediate recovery opportunity lives.

10.  Revenue Cycle Best Practices for Dermatology (2026)

Top-performing dermatology practices don't just submit cleaner claims — they've built systems that catch errors before they become denials. These are the six non-negotiable habits that consistently separate high-revenue dermatology practices from the rest.

✅  Best Practice 1: Verify Eligibility 48 Hours Before Appointment

Don't wait until check-in to verify insurance. Run eligibility checks — confirming active coverage, copay, deductible status, remaining out-of-pocket, and prior auth triggers — at least 48 hours before each scheduled visit. This single workflow change reduces front-end denials by up to 30% and eliminates the awkward "your insurance is not active" conversation at the front desk.

✅  Best Practice 2: Build CPT–ICD-10 Crosswalk Templates in Your EHR

Pre-link your most common dermatology CPT codes with appropriate ICD-10 codes inside your EHR or superbill. When a dermatologist documents cryotherapy for actinic keratoses, the system should present the right ICD-10 automatically. This reduces coder intervention, prevents mismatched diagnosis linkage, and cuts denial rates significantly across your highest-volume encounter types.

✅  Best Practice 3: Track These KPIs Weekly — Not Monthly

Clean claim rate (target >95%) | Days in AR (target <30) | Denial rate (target <5%) | Net collection rate (target >96%) | Charge lag (target <24 hours) | Denial overturn rate (target >70%). Practices that track weekly respond to problems before they compound into AR backlogs. Monthly tracking means you're reading a post-mortem rather than running a live operation.

✅  Best Practice 4: Work All Denials Within 5 Business Days

Every denied claim needs a hard deadline. Implement a denial work queue where no claim sits untouched for more than five business days. Sort by dollar value — your highest-value denials should never age past the payer's appeal window. Track your overturn rate quarterly; it is the clearest measure of your billing team's effectiveness at recovery.

✅  Best Practice 5: Conduct Quarterly Coding Audits (20–25 Records per Provider)

Internal audits should sample a minimum of 20–25 records per dermatologist per quarter. Focus on E&M level consistency, biopsy technique documentation accuracy, modifier usage correctness, and alignment between documentation and submitted codes. External audits annually are even better — fresh eyes catch patterns that internal teams have stopped seeing.

✅  Best Practice 6: Enforce a 24-Hour Charge Capture Rule

Every procedure performed today must be in the billing system by close of business tomorrow — no exceptions. Charge lag is silent revenue loss. In a high-volume dermatology practice where dozens of procedures happen daily, a single day of missed charge capture compounds quickly into significant uncollected revenue over a month, a quarter, and a year.

11.  Compliance & Audit Risk in Dermatology Billing

Dermatology consistently appears on the OIG Work Plan due to high procedure volume, the complexity of cosmetic vs. medical coding distinctions, and the high-RVU exposure inherent in Mohs surgery billing. Here are the specific areas your compliance program must address in 2026.

Risk Area	2026 Red Flag Threshold	Recommended Mitigation
99215 E&M utilization rate	Above 30% for established patients	National average is ~15%; audit for MDM documentation quality across providers
17004 billing rate	100% at maximum without individual lesion counts	Each lesion must be counted and documented; run internal spot audits monthly
Mohs claims missing pathology	Any Mohs claim without fresh-tissue interpretation	Op note must include real-time interpretation documentation — not lab attachment
Cosmetic billing under medical codes	High seborrheic keratosis or skin tag removal rate	Medical necessity must be explicit; issue ABN when necessity is uncertain
Skin substitute (Q-code) billing	Overuse without documented wound progression	CMS is targeting derm Q-code billing patterns in 2026 — audit closely

🛡️  Build Your Compliance Program Before an Auditor Knocks

The practices that survive OIG and RAC audits intact are the ones that built compliance programs proactively. A functional dermatology compliance program includes: written coding and documentation policies reviewed annually, quarterly provider education and coding feedback sessions, a confidential reporting mechanism for suspected billing errors, annual internal audits with documented corrective action plans, and a designated compliance officer or function. If your practice does not have these elements in place, the time to build them is now — not after you receive an audit notice.

12.  In-House vs. Outsourced Dermatology Billing — An Honest Comparison

This is one of the most consequential strategic decisions in dermatology practice management. There is no universal right answer — but there are clear patterns in where each model performs better, and where the economics favor one over the other.

Factor	In-House Billing	Specialized Outsourced Billing
Cost Structure	Higher: staff salaries, benefits, software, training costs	Typically 3–6% of collected revenue; no HR overhead
Coding Expertise	Limited by individual staff experience and turnover cycles	Specialty-certified coders (CPC, CPCD) with dermatology case volume
Claim Denial Rate	Typically 8–14% without dedicated specialty focus	Often 2–5% with experienced derm-specialized billing teams
Staff Turnover Risk	High: one departure disrupts the entire revenue cycle	Zero internal turnover risk; service continuity is guaranteed
Technology & Software	Practice pays for PM, EHR, clearinghouse, and reporting tools	Often bundled or discounted through billing company relationships
Compliance Monitoring	Requires dedicated internal compliance resources and training	Typically included — coding audits, payer policy tracking, HIPAA monitoring
Scalability	Difficult to scale quickly when adding providers or locations	Scales immediately with practice growth and volume changes
Transparency & Control	Maximum control; in-house team is immediately accessible	Depends on reporting quality — require weekly KPI dashboards contractually

💡  The Hybrid Billing Model — Best of Both Worlds

Many high-performing dermatology practices succeed with a hybrid approach: keep a billing coordinator in-house for same-day charge capture, patient communication, and prior auth management — while outsourcing complex coding, claims submission, denial management, and AR follow-up to a specialized billing company. This model maintains front-desk control while capturing the expertise and economics of a dedicated billing partner.

13.  Billing Partner Scoring Matrix — How to Evaluate a Dermatology Billing Company

Not all medical billing companies are created equal — and dermatology billing is not a general practice. Use this weighted scoring matrix to evaluate any billing partner before signing a contract. Score each vendor 1–5 on each criterion, multiply by weight, and compare total scores.

Evaluation Criteria	Weight	What to Ask or Look For	Score (1–5)
Dermatology Specialization & Coder Credentials	25%	Active CPC or CPCD-certified coders; verifiable dermatology-specific case volume; client references from derm practices	__ / 5
Documented Denial Rate & Clean Claim Rate	20%	Request verifiable data showing denial rate <5% and clean claim rate >95% — not just promises	__ / 5
Technology & EHR/PM Integration	15%	Direct integration with your existing EHR; no manual rekeying; real-time claim status visibility	__ / 5
Reporting Transparency & KPI Dashboards	15%	Weekly or monthly KPI reports; client portal with denial detail, AR aging, and collection rate tracking	__ / 5
Compliance Program (OIG, HIPAA, Audits)	10%	Active written compliance plan; annual coding audits included in service agreement; HIPAA BAA in place	__ / 5
Credentialing & Re-Credentialing Support	10%	Full-service payer credentialing; tracks expiration dates; supports new provider onboarding efficiently	__ / 5
Client Retention Rate & References	5%	Above 90% annual retention rate; willing to provide direct, verifiable references from dermatology practices	__ / 5

14.  FAQ — 10 Most-Asked Dermatology Billing Questions

These are the billing questions dermatologists, practice managers, and billing teams search for most in 2026. Each one answered directly.

Q1: What is the most commonly undercoded CPT in dermatology billing?

The skin biopsy codes particularly the 2019-era codes 11102–11107 are the most chronically undercoded. Many practices still default to old habits or fail to document biopsy technique, which results in either an incorrect code or a lower-reimbursing one. Tangential and incisional biopsies carry different RVUs, and the distinction is financially meaningful across high visit volumes.

Q2: Can I bill a -25 modifier every time I do a procedure on the same day?

Only if the E&M service is significant and separately identifiable meaning the visit clearly addressed a clinical issue beyond the standard pre-procedure assessment. If the entire visit was about planning and performing the procedure, modifier -25 is not appropriate. Document what you assessed independently, what you decided clinically, and why it was meaningful beyond the procedure itself.

Q3: How many lesions can I destroy before switching from 17003 add-ons to 17004?

17004 applies when 15 or more premalignant lesions are destroyed in a single session. For 1 lesion, use 17000. For 2–14 lesions, use 17000 + 17003 (reported once per additional lesion beyond the first). Never bill 17004 without counting and explicitly documenting the number of lesions treated in the chart note — it is an active audit trigger.

Q4: Does Medicare cover cosmetic dermatology procedures?

No. Medicare does not cover procedures performed purely for cosmetic reasons, including removal of benign lesions without documented medical necessity such as irritation, bleeding, infection risk, or obstruction. Before any procedure with potential cosmetic ambiguity, issue an Advance Beneficiary Notice (ABN) and document the clinical rationale thoroughly in the medical record.

Q5: What is the global period for most dermatology procedures?

Minor surgeries including most shave removals and small excisions carry a 10-day global period. More complex excisions and reconstructions may carry a 90-day global. Mohs surgery carries a 0-day global period, meaning all post-operative care, wound checks, and suture removal are separately billable on the date they are performed.

Q6: How do I bill reconstruction performed the same day as Mohs surgery?

Reconstruction following Mohs is separately billable on the same date of service. Use the appropriate repair code based on defect size and method — linear repair (12001–13160), adjacent tissue transfer or flap (14000–14302), or skin graft codes. Document the defect dimensions separately from the Mohs operative map, and ensure the reconstruction note includes the final post-Mohs defect size.

Q7: What is the most common ICD-10 coding mistake in dermatology?

Using unspecified codes when more specific codes are available — particularly for skin malignancies. Billing C44.91 (skin malignancy, unspecified site) when the documentation clearly identifies the anatomical location and cell type is both a medical necessity risk and a denial trigger. Always code to the most specific level your documentation supports.

Q8: Can I bill patch testing and an E&M on the same day?

Yes, with modifier -25 on the E&M (99202–99215) if the visit includes a clinically separate and significant assessment beyond administering the patch test itself. Patch test codes (95044, 95052) pair regularly with E&M in dermatology allergy workups — but document the independent clinical assessment clearly in the body of the visit note.

Q9: What is a typical actinic keratosis destruction encounter worth in 2026?

A typical AK destruction session treating 3–4 lesions (17000 + two 17003 add-ons) combined with a Level 3 established E&M (99213 with modifier -25) yields approximately $185–$265 from Medicare, depending on your geographic practice expense adjustment factor. Commercial payer rates are typically 15–30% higher depending on your contracted fee schedule.

Q10: What is the most effective approach to appealing a denied Mohs surgery claim?

The most effective Mohs appeals include the complete operative note with stage-by-stage and block-by-block documentation, the same-day fresh-tissue pathology report confirming positive and final clear margins, the anatomical stage map, peer-reviewed literature supporting Mohs for that tumor type and anatomical location, and a signed physician attestation letter. Submit within the payer's appeal window typically 60 to 180 days from the denial date via certified mail or electronic submission with delivery confirmation.

Free Demo

15.  Full Disclaimer

⚠️  IMPORTANT LEGAL & COMPLIANCE DISCLAIMER

Educational Purpose Only

The information contained in this guide is provided for general educational and informational purposes only. It does not constitute legal, medical, financial, or professional billing or coding advice. Nothing in this document creates a provider-client, attorney-client, or any other professional relationship between Sirius Solutions Global and the reader.

Code & Fee Schedule Accuracy

CPT codes are proprietary and copyrighted by the American Medical Association (AMA). All CPT code descriptions and reimbursement values cited in this guide are approximations based on the CMS 2025–2026 Medicare Physician Fee Schedule and national conversion factors. Actual reimbursement amounts vary significantly by geographic location, facility vs. non-facility setting, individual payer contracts, and annual CMS fee schedule updates. ICD-10-CM codes are maintained by the National Center for Health Statistics (NCHS) and updated annually; always verify current code sets using the official CMS ICD-10 browser.

No Liability

Sirius Solutions Global makes no representations or warranties — express or implied — regarding the accuracy, completeness, or fitness for a particular purpose of any information contained in this guide. Sirius Solutions Global does not accept liability for errors, omissions, or outcomes resulting from the use of this information. Billing regulations, payer policies, and coding guidelines change frequently; always verify with current official sources before implementing any coding or billing practice.

Professional Consultation Required

Before implementing any billing practice, coding strategy, or operational change based on content in this guide, readers should consult with a qualified Certified Professional Coder (CPC), a healthcare compliance attorney, or a credentialed billing and coding specialist. For Medicare and Medicaid-specific guidance, consult your Medicare Administrative Contractor (MAC) or state Medicaid program directly.

Compliance & Anti-Fraud Notice

Intentional upcoding, unbundling, billing for services not rendered, or otherwise misrepresenting services to obtain reimbursement constitutes healthcare fraud under the False Claims Act and is subject to significant civil and criminal penalties. The information in this guide is intended solely to help practices code accurately and completely not to encourage or facilitate improper billing practices in any form. When in doubt, consult a qualified compliance professional.

(469) 694-5375   |   info@siriussolutionsglobal.com   |   billing.siriussolutionsglobal.com